OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study
Wim Schrauwen, Joris Van de Cavey, Guy Vingerhoets, et al.
Journal of the International Neuropsychological Society (2020) Vol. 26, Iss. 8, pp. 806-814
Open Access | Times Cited: 13

Showing 13 citing articles:

Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies
Aicha B. C. Dijkshoorn, Haike E. van Stralen, Maurits Sloots, et al.
Psycho-Oncology (2021) Vol. 30, Iss. 5, pp. 635-648
Open Access | Times Cited: 108

Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105

Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
Longqin Lv, Shanping Mao, Huimin Dong, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 54

Advances in Therapeutic Research on Chemotherapy-Related Cognitive Impairment
立石 刘
World Journal of Cancer Research (2025) Vol. 15, Iss. 01, pp. 9-15
Closed Access

Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis
Noelia Durán-Gómez, Casimiro Fermín López-Jurado, Marta Nadal-Delgado, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2363-2363
Open Access | Times Cited: 17

Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 22

Brain White Matter Microstructure as a Risk Factor for Cognitive Decline After Chemotherapy for Breast Cancer
Michiel B. de Ruiter, Liesbeth Reneman, Jacobien M. Kieffer, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 35, pp. 3908-3917
Closed Access | Times Cited: 11

Alteraciones cognitivas por quimioterapia en pacientes con cáncer de mama:
Bernardo Arce, Nora Grañana
Revista de la Facultad de Ciencias Médicas de Córdoba (2023) Vol. 80, Iss. 2, pp. 126-133
Open Access | Times Cited: 2

Cognitive effects of chemotherapy: An integrative review
Carli Shaw, Adele Baldwin, Carina Anderson
European Journal of Oncology Nursing (2021) Vol. 54, pp. 102042-102042
Open Access | Times Cited: 4

Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: A systematic review and meta-analysis
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1

Reviews of Science for Science Librarians: Chemobrain
Tony Stankus
Science & Technology Libraries (2021) Vol. 40, Iss. 4, pp. 341-357
Closed Access | Times Cited: 1

Page 1

Scroll to top